Gallbladder and Biliary Tract
- Nab-Paclitaxel Does Not Increase Overall Survival in Biliary Tract Cancer
- Bezafibrate and Linerixibat May Improve Pruritus in Primary Biliary Cholangitis
- Percutaneous Cholecystostomy Rates Increased During COVID-19 Pandemic
- Bezafibrate, Ursodeoxycholic Acid May Be Beneficial in Primary Biliary Cholangitis
- Choledochoscopic Gallbladder-Preserving Cholecystolithotomy Alternative to Cholecystectomy
- Increase in Cholangiocarcinoma Incidence Not Fully Explained by Reclassification
- Guided Imagery Meditation Improves Outcomes After Cholecystectomy
- Progression from Asymptomatic to Symptomatic Gallstones: The Risk Factors
- GLP-1 RA Use May Increase Risk for Gallbladder, Biliary Diseases
- Adjuvant, Neoadjuvant Chemotherapy Use Low in Surgically Resected Gallbladder Cancers
- EUS, MRCP Comparable for Detecting Choledocholithiasis at Intermediate Risk
- EUS-Guided Drainage Studied in Noncholecystitis Gallbladder Disease
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
